Case Study: Idorsia Pharmaceuticals achieves GxP-compliant long-term access to research and clinical trial data with Arkivum

Idorsia Pharmaceuticals secures 20/30/50-year GxP data access with Arkivum

Idorsia Pharmaceuticals, a Swiss biopharmaceutical company formed from the de-merger of Actelion, faced the challenge of securely storing and ensuring long-term compliant access to a large volume of valuable research and clinical trial data. This included legacy data from Actelion, data returning from partners, and new data being generated. They selected Arkivum to provide a GxP-compliant e-archive solution to meet this need.

The solution implemented by Arkivum provides Idorsia with a secure digital archive that guarantees the integrity, chain of custody, and audit trail of their data for decades to come. This ensures that the company can confidently provide evidence to future auditors, proving the complete history of any product or clinical trial documentation, thereby safeguarding its regulatory compliance.

Idorsia Pharmaceuticals